Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 19.43% is 19% below its 5-year average of 24.09%, near the high end of its 5-year range (-65.24%–38.84%).
3.78% below its 12-month average of 20.19%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 25.82%.
OPERATING MARGIN
19.43%
OPERATING MARGIN AVG TTM
20.19%
OPERATING MARGIN AVG 3Y
27.58%
OPERATING MARGIN AVG 5Y
24.09%
OPERATING MARGIN AVG 10Y
19.08%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3.78%
CURRENT VS 3Y AVG
-29.55%
CURRENT VS 5Y AVG
-19.35%
CURRENT VS 10Y AVG
+1.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 711 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lantheus Holdings, Inc.
Market Cap
$6.51B
Operating Margin
19.43%
TTM Avg
20.19%
3Y Avg
27.58%
5Y Avg
24.09%
Market Cap
$6.56B
Operating Margin
12.93%
TTM Avg
11.47%
3Y Avg
6.80%
5Y Avg
6.51%
Market Cap
$6.59B
Operating Margin
4.50%
TTM Avg
4.35%
3Y Avg
-1.93%
5Y Avg
-10.04%
Market Cap
$6.68B
Operating Margin
13.46%
TTM Avg
14.22%
3Y Avg
14.89%
5Y Avg
15.72%
Market Cap
$6.06B
Operating Margin
-362.95%
TTM Avg
-1052.99%
3Y Avg
-3382.94%
5Y Avg
-3698.56%
Market Cap
$6.01B
Operating Margin
17.61%
TTM Avg
2.04%
3Y Avg
3.68%
5Y Avg
13.44%
Market Cap
$5.94B
Operating Margin
-153.08%
TTM Avg
-197.00%
3Y Avg
-9782.25%
5Y Avg
-6521.50%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | $6.51B | 19.43% | 20.19% | 27.58% | 24.09% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.56B | 12.93% | 11.47% | 6.80% | 6.51% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.59B | 4.50% | 4.35% | -1.93% | -10.04% |
| Immunovant, Inc. (IMVT)vs › | $6.66B | 0.00% | 0.00% | 0.00% | 0.00% |
| Chemed Corporation (CHE)vs › | $6.68B | 13.46% | 14.22% | 14.89% | 15.72% |
| GRAIL Inc. (GRAL)vs › | $6.06B | -362.95% | -1052.99% | -3382.94% | -3698.56% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $6.01B | 17.61% | 2.04% | 3.68% | 13.44% |
| Alkermes plc (ALKS)vs › | $7.08B | 17.21% | 22.11% | 17.14% | 11.01% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.94B | -153.08% | -197.00% | -9782.25% | -6521.50% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.82B | 11.92% | 0.31% | -1.06% | -68.44% |
Gross Margin
60.1%
Operating Margin
19.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 25.82% |
| 2026-03-31 | 21.55% |
| 2025-12-31 | 18.97% |
| 2025-09-30 | 11.36% |
| 2025-06-30 | 23.27% |
| 2025-03-31 | 27.38% |
| 2024-12-31 | 29.12% |
| 2024-09-30 | 35.31% |
| 2024-06-30 | 26.07% |
| 2024-03-31 | 27.13% |
| 2023-12-31 | 38.84% |
| 2023-09-30 | 35.12% |
| 2023-06-30 | 38.59% |
| 2023-03-31 | -3.11% |
| 2022-12-31 | -65.24% |
| 2022-09-30 | 35.83% |
| 2022-06-30 | 28.25% |
| 2022-03-31 | 28.21% |
| 2021-12-31 | -27.27% |
| 2021-09-30 | -14.04% |
| 2021-06-30 | -26.50% |
| 2021-03-31 | 16.89% |
| 2020-12-31 | -0.56% |
| 2020-09-30 | -5.93% |
| 2020-06-30 | -8.40% |
| 2020-03-31 | 7.86% |
| 2019-12-31 | 13.92% |
| 2019-09-30 | 9.93% |
| 2019-06-30 | 16.96% |
| 2019-03-31 | 18.69% |
| 2018-12-31 | 19.64% |
| 2018-09-30 | 18.54% |
| 2018-06-30 | 18.61% |
| 2018-03-31 | 18.32% |
| 2017-12-31 | 11.33% |
| 2017-09-30 | 16.04% |
| 2017-06-30 | 20.15% |
| 2017-03-31 | 14.66% |
| 2016-12-31 | 16.33% |
| 2016-09-30 | 17.24% |
| 2016-06-30 | 18.19% |
| 2016-03-31 | 23.11% |
| 2015-12-31 | 17.40% |
| 2015-09-30 | 18.09% |
| 2015-06-30 | 7.31% |
| 2015-03-31 | 15.21% |
| 2014-12-31 | 15.24% |
| 2014-09-30 | 12.18% |
| 2014-06-30 | 13.20% |
| 2014-03-31 | 11.58% |
| 2013-12-31 | -1.86% |
| 2013-09-30 | -6.49% |
| 2013-06-30 | -5.32% |
| 2013-03-31 | -13.01% |
| 2012-12-31 | 1.55% |
